Evidence map›Paper›PMID 36605709›Full record

ArticleBiotechnologia2021

Synthesis of quercetin-functionalized silver nanoparticles by rapid one-pot approach.

Sureshbabu Ram Kumar Pandian, Selvaraj Kunjiappan, Vigneshwaran Ravishankar, Velmurugan Sundarapandian

Open access · diamondAbstract read
In one paragraph

Article in Biotechnologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Comparative evaluation of quercetin, rutin, and their nanoparticles: enhanced antimicrobial and antioxidant activities.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Synthesis of AgJournal of functional biomaterials · 2025
    Article
  5. Article
  6. Article
  7. ACS omega · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sureshbabu Ram Kumar PandianDepartment of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India.
Selvaraj KunjiappanDepartment of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India.
Vigneshwaran RavishankarDepartment of Biotechnology, Mepco Schlenk Engineering College, Sivakasi, Tamil Nadu, India.
Velmurugan SundarapandianDepartment of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India.
Kalasalingam Academy of Research and Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology plays a pivotal role in all areas of science, and the synthesis and surface modification of nanoparticles are crucial in this field. Metal nanoparticles synthesized using plant extracts or phytocompounds are highly significant in the development of various therapeutics and diagnostics. In the present study, we report the one-pot and rapid synthesis of silver nanoparticles (AgNPs) by quercetin, a flavonoid found in various edible plants. The nanoparticles were then characterized using UV-VIS spectrophotometry, Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The role of quercetin in the synthesis of silver nanoparticles was demonstrated. The nanomaterial was 20-30 nm in size and spherical in shape. The silver nanoparticles were also confirmed to show antioxidant activity at 80 μg/ml concentration

Indexed as

AgNPsantioxidantbioflavonoidone-pot synthesisquercetin

Identifiers

PMID36605709
PMCPMC9642916
OpenAlexW3140474349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.